Trial of New Alzheimer’s Drug Reports Disappointing Results June 16, 2022 crenezumab +6 failed to prevent early symptoms or slow cognitive decline IFTTT NYT NYT > Business NYTimes The drug the latest setback in the long quest to find effective therapies for the disease. crenezumab failed to prevent early symptoms or slow cognitive decline IFTTT NYT NYT > Business NYTimes The drug the latest setback in the long quest to find effective therapies for the disease.